{"id":"NCT01457352","sponsor":"Sun Pharma Advanced Research Company Limited","briefTitle":"Efficacy and Safety of SPARC0921 in Subjects With Spasticity","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-11-14","primaryCompletion":"2017-08-25","completion":"2017-08-25","firstPosted":"2011-10-21","resultsPosted":"2019-06-18","lastUpdate":"2019-06-18"},"enrollment":392,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Spasticity"],"interventions":[{"type":"DRUG","name":"SPARC0921","otherNames":[]},{"type":"DRUG","name":"Placebo0921","otherNames":[]}],"arms":[{"label":"SPARC0921","type":"EXPERIMENTAL"},{"label":"Placebo0921","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess whether SPARC0921 demonstrate efficacy and safety in the treatment of spasticity.","primaryOutcome":{"measure":"Treatment Failure Rate","timeFrame":"Week 22","effectByArm":[{"arm":"SPARC0921","deltaMin":36.1,"sd":null},{"arm":"Placebo0921","deltaMin":43.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2062"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":73,"countries":["United States","Germany","Hungary","Russia","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":147},"commonTop":["Muscle spasticity","Fatigue","Headache","Nausea","Urinary tract infection"]}}